Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Fatty Liver Treatment Market?

The market size for treating fatty liver has seen significant expansion in the past few years. The current prediction is an increase from $23.73 billion in 2024 to a sizeable $25.05 billion in 2025, representing a compound annual growth rate (CAGR) of 5.5%. Factors leading to this growth during the historic period include an obesity epidemic, inactive lifestyles, unhealthful eating habits, a lack of treatment alternatives, and heightened awareness through campaigns.

In the upcoming years, the fatty liver treatment market is forecasted to undergo substantial growth, surging to a whopping $32.98 billion in 2029 with a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this projected growth during the forecast period include an uptick in disease prevalence, elevation in healthcare expenditure, an increase in diabetes and metabolic syndrome, along with advancements in therapeutic innovation. Additionally, the period is expected to see trends such as precision medical techniques, lifestyle modification programs, targeted treatments for Nash, non-intrusive monitoring devices, and progressive technological developments.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

What Underlying Factors Are Supporting The Fatty Liver Treatment Market Growth?

The expected surge in alcohol intake is predicted to stimulate the expansion of the fatty liver treatment market. The term alcohol intake pertains to the consumption of drinks with alcohol, a mind-altering substance that has inhibitory effects on the central nervous system. Drinking alcohol could exacerbate fatty liver disease, potentially resulting in more acute liver disorders, such as alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For example, according to the HRB National Drugs Library, a government-funded initiative in Ireland, alcohol consumption in Scotland spiked to 10.2 liters of pure alcohol for each individual aged 15 or older in 2022, a rise of 7.6% from 2021. This suggests an alarming increase in alcohol consumption despite continuous efforts toward public health to minimize its intake. Consequently, the rise in alcohol intake is fueling the progress of the fatty liver treatment market.

How Does The Fatty Liver Treatment Market Differ By Segment?

The fatty liver treatmentmarket covered in this report is segmented –

1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants; Chemotherapy Drugs; Targeted Therapy; Vaccines; Anti-Viral Drugs

2) By Disease Type: Hepatitis; Liver Cancer; Non-Alcoholic Fatty Liver Disease; Other Diseases

3) By End User: Hospitals; Ambulatory Surgery Centers; Other End Users

Subsegments:

1) By Anti-Rejection Drugs Or Immunosuppressants: Corticosteroids; Calcineurin Inhibitors; mTOR Inhibitors

2) By Chemotherapy Drugs: Conventional Chemotherapy Agents; Novel Chemotherapeutics Under Investigation

3) By Targeted Therapy: Small Molecule Inhibitors; Monoclonal Antibodies

4) By Vaccines: Therapeutic Vaccines; Preventive Vaccines

5) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs); Nucleos(t)ide Analogs

What Are The Dominant Trends Currently Seen In The Fatty Liver Treatment Market?

Innovation in products is an emerging trend that is gaining traction in the market for fatty liver treatment. Major businesses in this market are focusing on creating innovative products to bolster their market position. For example, in March 2023, Akero Therapeutics, a biotech firm based in the US, announced positive Phase II findings for efruxifermin, a compound intended for the non-invasive treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). The compound is a unique Fc-FGF21 fusion protein that emulates the biologic activity of fibroblast growth factor 21 (FGF21), which controls a variety of metabolic pathways and cellular activities.

Who Are The Global Leaders Steering The Fatty Liver Treatment Market Forward?

Major companies operating in the fatty liver treatment market include Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithkline plc, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Fatty Liver Treatment Market?

North America was the largest region in the fatty liver treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12581&type=smp

Browse Through More Reports Similar to the Global Fatty Liver Treatment Market 2025, By The Business Research Company

Liver Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Fatty Amines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fatty-amines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model